SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant investor skepticism as concerns over leadership continuity and the long-term competitive threat of AI overshadow strong earnings results and raised financial guidance. The community is deeply divided, with some calling the current valuation a generational buying opportunity for a cash-flow powerhouse, while others argue the business model faces obsolescence from emerging AI-driven competitors.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors digest a massive equity raise to fuel long-term AI infrastructure spending, alongside major compute partnerships with SpaceX and Intel that reinforce its lead in the hardware ecosystem. Community sentiment remains split between excitement over these long-term strategic moves and skepticism regarding the dilutive impact of capital raises on existing shareholders.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense downward pressure driven by market anxiety over the massive capital expenditure required for AI infrastructure and speculation regarding potential share dilution to fund these initiatives. Despite the company's strong revenue growth and ad business, the community is deeply divided, with bears pointing to overspending risks and leadership concerns while bulls advocate for accumulating shares at what they perceive to be an undervalued forward earnings multiple.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

XOVR is trending as investors seek liquid, accessible exposure to SpaceX ahead of its highly anticipated IPO, with the community actively debating its concentration of private holdings versus peer ETFs. While some investors are bullish on its long-term potential as a private-public crossover vehicle, others are expressing frustration over stagnant price action and technical complexities surrounding how the fund values its illiquid SpaceX assets.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing intense volatility as investors debate the impact of broader market liquidity rotation into upcoming major IPOs and persistent geopolitical tensions. Community members are sharply divided between bulls confident in the stock's long-term AI-driven fundamentals and bears pointing to technical exhaustion and potential risks from institutional profit-taking.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors rotate capital into the highly anticipated SpaceX IPO and navigate broader concerns regarding AI infrastructure spending. Community sentiment is deeply polarized, with many traders viewing the current downturn as a result of institutional liquidity shifts, while others debate whether the company's aggressive AI investment strategy will provide the long-term ROI needed to sustain its valuation.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF ($DRAM) is seeing intense momentum as the memory supply shortage, driven by explosive AI demand, remains a key bottleneck for the entire semiconductor sector. Community discussion is dominated by bullish sentiment regarding the structural shift in memory pricing, long-term supply constraints stretching into 2027, and the fund's direct exposure to industry giants like Micron, SK Hynix, and Samsung.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending as investors weigh its pivot toward premium travel and high-speed connectivity via a new Starlink partnership against significant margin pressures from elevated jet fuel costs. The community is actively debating the stock's resilience, with many split between bullish optimism regarding potential Middle East de-escalation and bearish concerns over the airline's debt load and vulnerability to oil volatility.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

The Tema Space Innovators ETF (NASA) is experiencing significant retail interest as traders position themselves ahead of the highly anticipated SpaceX IPO, with community members actively discussing the potential for a rally as institutionally backed space-sector inflows accelerate. While some participants express caution regarding market volatility and sector-wide sentiment, bulls view current price levels as an attractive entry point to gain exposure to SpaceX and key satellite-tech holdings before the public listing.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney shares are rallying following a second-quarter earnings beat driven by strong performance in streaming and theme parks, which has reignited optimism regarding the company's growth trajectory under new leadership. The community is actively debating the sustainability of this momentum, weighing positive sentiment around share buybacks and margin improvements against ongoing concerns over the company's long-term strategic direction and legacy media headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene Therapy Published at the 2026 ASCO Annual Meeting

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene Therapy Published at the 2026 ASCO Annual Meeting Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene Therapy Published at the 2026 ASCO Annual Meeting PR Newswire AUSTIN, Texas, May 26, 2026 Trop-2 H-scores...

Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting

Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting Genprex Collaborators Present...

Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa Gene Therapy and PD-1 Antibodies to Treat Cancer

Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa Gene Therapy and PD-1 Antibodies to Treat Cancer Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa Gene Therapy and PD-1 Antibodies to Treat Cancer PR Newswire AUSTIN...

Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting

Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting Genprex Collaborators to...

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene Therapy To Be Released at the 2026 ASCO Annual Meeting

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene Therapy To Be Released at the 2026 ASCO Annual Meeting Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene...

Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa Gene Therapy

Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa Gene Therapy Genprex Signs Sponsored Research Agreement to Study Biomarkers that May...

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting Genprex Collaborators Present Positive...

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting Genprex Collaborators to Present...

Genprex to Participate at BIO Europe Spring 2026

Genprex to Participate at BIO Europe Spring 2026 Genprex to Participate at BIO Europe Spring 2026 PR Newswire AUSTIN, Texas, March 10, 2026 AUSTIN, Texas, March 10, 2026 /PRNewswire/ -- Genprex, Inc...

Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa Gene Therapy in Combination with Immunotherapies to Treat Cancer

Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa Gene Therapy in Combination with Immunotherapies to Treat Cancer Genprex Strengthens Intellectual Property...

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.

Current Price	$0.6536
Prev Close	$0.6361
Open	$0.64
Dividend Yield	0.00%
50-Day Moving Average	$0.9581
Beta	1.46
Avg. Volume	311,094.11
PE Ratio	-0.04

52-Week High	$55.00
52-Week Low	$0.6242
Market Capitalization	$6.73M
EPS (Annual)	-$17.40
Price to Book	0.35
Revenue Per Employee	$0.00

GNPXGenprex Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GNPX News